Twin Tree Management
AGIO icon

Twin Tree Management’s Agios Pharmaceuticals AGIO Stock Holding History

Twin Tree Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,400
Closed -$1.26M – 1316
2018
Q3 		$1.26M Hold
16,400
– – 0.01% 678
2018
Q2 		$1.38M Buy
+16,400
New +$1.43M 0.01% 716

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Twin Tree Management's AGIO Position: Q3 2024 in Review

Twin Tree Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2024, closing a stake of 52 shares — an estimated $2.24K sold.

Twin Tree Management first reported a position in AGIO in Q3 2019 and held it in 3 quarters. The position peaked at $91K in Q3 2020. 207 funds tracked by Wall St. Rank hold AGIO as of Q3 2024.

  • Twin Tree Management reported no remaining Agios Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Twin Tree Management sold 52 Agios Pharmaceuticals shares in Q3 2024, an estimated $2.24K.
  • Twin Tree Management first reported a position in Agios Pharmaceuticals in Q3 2019 and held it in 3 quarters.
  • Twin Tree Management's Agios Pharmaceuticals position peaked at $91K in Q3 2020.
  • 207 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2024.

Based on Twin Tree Management's 13F filing for Q3 2024, filed 13 Nov 2024.